Search details
1.
Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study.
Clin Cancer Res
; 28(11): 2270-2277, 2022 06 01.
Article
in English
| MEDLINE | ID: mdl-35344029
Results
1 -
1
de 1
1
Next >
>>